Zacks Research Raises Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Analysts at Zacks Research raised their FY2024 EPS estimates for shares of Teladoc Health in a research note issued to investors on Wednesday, November 13th. Zacks Research analyst R. Department now anticipates that the health services provider will earn ($1.15) per share for the year, up from their prior forecast of ($1.31). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.17) per share. Zacks Research also issued estimates for Teladoc Health’s Q4 2024 earnings at ($0.19) EPS, Q1 2025 earnings at ($0.38) EPS, Q2 2025 earnings at ($0.28) EPS, Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($1.05) EPS, Q1 2026 earnings at ($0.37) EPS, Q2 2026 earnings at ($0.22) EPS, Q3 2026 earnings at ($0.21) EPS and FY2026 earnings at ($0.89) EPS.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million.

Other equities analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Piper Sandler reduced their price target on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $10.00 price objective on shares of Teladoc Health in a research note on Tuesday, August 20th. Evercore ISI increased their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Canaccord Genuity Group dropped their price objective on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $12.08.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $9.06 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a one year low of $6.76 and a one year high of $22.54. The company’s 50-day simple moving average is $8.93 and its 200-day simple moving average is $9.34. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of -1.57 and a beta of 0.90.

Institutional Trading of Teladoc Health

A number of large investors have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Teladoc Health by 2.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock worth $641,000 after buying an additional 1,352 shares in the last quarter. Covestor Ltd boosted its stake in Teladoc Health by 58.1% in the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after purchasing an additional 1,403 shares during the period. Signaturefd LLC boosted its stake in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares during the period. Swiss National Bank boosted its stake in Teladoc Health by 0.6% in the 1st quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock worth $4,936,000 after purchasing an additional 1,800 shares during the period. Finally, Blue Trust Inc. boosted its stake in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Insider Activity at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the transaction, the chief operating officer now owns 78,309 shares in the company, valued at $560,692.44. This trade represents a 5.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas Mckinley bought 4,000 shares of Teladoc Health stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the acquisition, the director now directly owns 39,077 shares of the company’s stock, valued at $300,502.13. This represents a 11.40 % increase in their position. The disclosure for this purchase can be found here. Insiders have sold 20,051 shares of company stock worth $143,565 over the last quarter. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.